HIGH

Viona Pharmaceuticals Recalls 13,080 Tavaborole Topical Solution 5% Bottles (2025 Recall)

Viona Pharmaceuticals recalled 13,080 Tavaborole Topical Solution 5%, 10 mL bottles distributed nationwide in the United States. The recall covers Tavaborole Topical Solution 5%, Rx only, manufactured by Zydus Lifesciences Ltd. Discoloration linked to RES #97424 prompted the action. Consumers should stop using the product and contact Viona for guidance.

Quick Facts at a Glance

Recall Date
October 6, 2025
Hazard Level
HIGH
Brands
Zydus Lifesciences, Viona Pharmaceuticals
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Discoloration - Expansion of RES #97424

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact VIONA PHARMACEUTICALS INC or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Tavaborole Topical Solution 5% is a prescription antifungal treatment in a 10 mL bottle. It is used to treat fungal infections of the nails. The recalled product is distributed nationwide in the United States.

Why This Is Dangerous

Discoloration is identified as a manufacturing quality issue tied to RES #97424. The label indicates a potential defect in the product that could affect appearance or integrity.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

Consumers must stop using the product until guidance is provided. The recall affects a limited number of bottles but requires action to avoid continuing use of a potentially defective product.

Practical Guidance

How to identify if yours is affected

  1. Check NDC 72578-102-04 on the bottle label.
  2. Look for model numbers T400819, T400820, or T401969.
  3. Note the 10 mL bottle size and Rx only designation.

Where to find product info

Recall details can be found on the FDA enforcement page and through Viona Pharmaceuticals. Check the label for NDC and model numbers.

What timeline to expect

Remedy processing timelines were not specified. Expect guidance from the company within weeks.

If the manufacturer is unresponsive

  • File a complaint with the FDA if the company does not respond within a reasonable time frame.
  • Keep records of all communications and dates.

How to prevent similar issues

  • Always verify NDC and lot numbers when receiving prescription medications.
  • Ask pharmacists for documentation when receiving prescription products from unfamiliar manufacturers.
  • Monitor for recalls on prescription medications via the FDA recall site.

Documentation advice

Keep the product packaging, recall notice, and any correspondence with the company for future reference.

Product Details

Model numbers: T400819, T400820, T401969. NDC 72578-102-04. Rx only. Manufactured by Zydus Lifesciences Ltd., Changodar, Ahmedabad, India. Distributed by Viona Pharmaceuticals Inc., Cranford, NJ 07016. Quantity: 13,080 bottles. Distribution: USA nationwide. Recall date: 2025-10-06. Status: ACTIVE.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 13,080 bottles recalled
  • NDC 72578-102-04
  • Rx only Tavaborole Topical Solution 5% 10 mL
  • Manufactured in India by Zydus Lifesciences
  • Distributed nationwide in the USA

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
T400819
T400820
T401969
UPC Codes
72578-102
72578-102-04
Affected States
ALL
Report Date
October 22, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more